Clinical Trial: A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Dalfampridine Treatment for Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Brief Summary: Determine whether dalfampridine (Ampyra) can improve visual function in patients who have had nonarteritic ischemic optic neuropathy (NAION) with stable visual impairment.